Friday, July 10, 2026

pharma · Test of vasocontriction properties for classification of topical steroid potency

Cassopeia Pharmaceuticals Pvt

Cassiopea S.p.A is a pharma organization headquartered in LAINATE, IT. Primary therapeutic focus areas include Test of vasocontriction properties for classification of topical steroid potency. NovaPharmaNews links 1 clin

Chandigarh, IN HQ
2020 Founded
4 Employees
EMA registrant Type
Company details
Status
Public
HQ
Chandigarh, IN
Founded
2020
Employees
4
Programs
1
Drugs
6
Patents
12
Clinical program

CB-03-01/39

Phase 1 · other · Test of vasocontriction properties for classification of topical steroid potency

CB-03-01/39 for Test of vasocontriction properties for classification of topical steroid potency is a Phase 1 program (other) at Cassiopea S.p.A. with 1 ClinicalTrials.gov record(s).

Internal code CB-03-01/39

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Cassiopea S.p.A.
Phase
Phase 1
Modality
other
Indication
Test of vasocontriction properties for classification of topical steroid potency
Status
active
Trials
1